OMass Therapeutics logo

OMass Therapeutics

A biotechnology company using mass spectrometry platforms for drug discovery and the development of therapeutics.

1

Funding Rounds

$100.0m

Money raised

Overview

A biotechnology company using mass spectrometry platforms for drug discovery and the development of therapeutics.

Funding series

Funding Series Analysis

The company OMass Therapeutics has raised a total of $100m in funding over 1 rounds.

Key Insights:

  • OMass Therapeutics Series B round, April 28, 2022: $100m
OMass Therapeutics logo
OMass Therapeutics Series B round, April 28, 2022 $100m

Industries

OMass Therapeutics is active in the following industries: